Author Question: Under what conditions will the alveolar PACO2 rise above normal? a. If both metabolic rate and ... (Read 56 times)

tth

  • Hero Member
  • *****
  • Posts: 579
Under what conditions will the alveolar PACO2 rise above normal?
 
  a. If both metabolic rate and ventilation in-crease (e.g., through exercise)
  b. If carbon dioxide production decreases relative to VA
  c. If VA decreases relative to carbon dioxide production
  d. When the patient is febrile

Question 2

What is the approximate normal level of carbon dioxide production (CO2) for an adult?
 
  a. 200 ml/min
  b. 250 ml/min
  c. 4200 ml/min
  d. 6000 ml/min



Qarqy

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

ANS: C
The PACO2 will increase above this level if carbon dioxide production increases while alveolar ventilation remains constant or when alveolar ventilation decreases while CO2 remains constant.

Answer to Question 2

ANS: A
In a healthy individual the normal CO2 of is approximately 200 ml/min.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library